Form D · Biotechnology
Juneau Biosciences, LLC
Salt Lake City, UT · CIK 0001400105
Offering snapshot reported Dec 4, 2013 · SEC filing
- Reported sold
- $25K Offering amount: $11.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 22, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 4, 2013 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Jun 13, 2012 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jul 20, 2011 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Mar 1, 2011 | Amendment | $3,761,000 | $3,511,000vs May 24, 2010 | 32 | SEC filing |
| May 24, 2010 | Initial | $250,000 | No comparison | 3 | SEC filing |
| Mar 27, 2009 | Initial | $2,600,000 | No comparison | Not reported | SEC filing |
| Dec 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-207342
Source: Form D, filed Dec 4, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hans Albertsen | Executive |
| Linda Gould | Executive |
| Rich Linder | Director |
| James Marsh | Director |
| Lesa Nelson | Director |
| Dinesh Patel | Director |
| Bradley Carling Robinson | Executive |
| Eric L Robinson | Director, Executive |
| Ken Ward | Director, Executive |
| Kenneth Ward | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2749 East Parleys Way Suite 210
Salt Lake City, UT, 84109
Salt Lake City, UT, 84109